Engineering and Characterization of a Biomimetic Microchip for Differentiating Mouse Adipocytes in a 3D Microenvironment

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2022 Feb 15

PMID 35166994

Authors

Yu-Ting Chen

Latha Ramalingam

Celine R Garcia

Zhenya Ding

Jiangyu Wu

Naima Moustaid-Moussa

Wei Li

Affiliations

Soon will be listed here.

Abstract

Although two-dimensional (2D) cell cultures are the standard in cell research, one pivotal disadvantage is the lack of cell-cell and cell-extracellular matrix (ECM) signaling in the culture milieu. However, such signals occur in three-dimensional (3D) in vivo environments and are essential for cell differentiation, proliferation, and a range of cellular functions. In this study, we developed a microfluidic device to proliferate and differentiate functional adipose tissue and adipocytes by utilizing 3D cell culture technology. This device was used to generate a tissue-specific 3D microenvironment to differentiate 3T3-L1 preadipocytes into either visceral white adipocytes using visceral adipose tissue (VAT) or subcutaneous white adipose tissue (SAT). The microchip has been tested and validated by functional assessments including cell morphology, inflammatory response to a lipopolysaccharide (LPS) challenge, GLUT4 tracking, and gene expression analyses. The biomimetic microfluidic chip is expected to mimic functional adipose tissues that can replace 2D cell cultures and allow for more accurate analysis of adipose tissue physiology.

References

Juppner H . The genetic basis of progressive osseous heteroplasia. N Engl J Med. 2002; 346(2):128-30. DOI: 10.1056/NEJM200201103460212. View

Pek Y, Wan A, Ying J . The effect of matrix stiffness on mesenchymal stem cell differentiation in a 3D thixotropic gel. Biomaterials. 2009; 31(3):385-91. DOI: 10.1016/j.biomaterials.2009.09.057. View

Edmondson R, Broglie J, Adcock A, Yang L . Three-dimensional cell culture systems and their applications in drug discovery and cell-based biosensors. Assay Drug Dev Technol. 2014; 12(4):207-18. PMC: 4026212. DOI: 10.1089/adt.2014.573. View

Luca A, Mersch S, Deenen R, Schmidt S, Messner I, Schafer K . Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines. PLoS One. 2013; 8(3):e59689. PMC: 3608563. DOI: 10.1371/journal.pone.0059689. View

Huh D, Hamilton G, Ingber D . From 3D cell culture to organs-on-chips. Trends Cell Biol. 2011; 21(12):745-54. PMC: 4386065. DOI: 10.1016/j.tcb.2011.09.005. View

Maltman D, Przyborski S . Developments in three-dimensional cell culture technology aimed at improving the accuracy of in vitro analyses. Biochem Soc Trans. 2010; 38(4):1072-5. DOI: 10.1042/BST0381072. View

Cukierman E, Pankov R, Stevens D, Yamada K . Taking cell-matrix adhesions to the third dimension. Science. 2001; 294(5547):1708-12. DOI: 10.1126/science.1064829. View

Abbott A . Cell culture: biology's new dimension. Nature. 2003; 424(6951):870-2. DOI: 10.1038/424870a. View

Kunz F, Bergemann C, Klinkenberg E, Weidmann A, Lange R, Beck U . A novel modular device for 3-D bone cell culture and non-destructive cell analysis. Acta Biomater. 2010; 6(9):3798-807. DOI: 10.1016/j.actbio.2010.03.015. View

10.

Pampaloni F, Reynaud E, Stelzer E . The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol. 2007; 8(10):839-45. DOI: 10.1038/nrm2236. View

11.

Horman S, To J, Orth A . An HTS-compatible 3D colony formation assay to identify tumor-specific chemotherapeutics. J Biomol Screen. 2013; 18(10):1298-308. DOI: 10.1177/1087057113499405. View

12.

Ravi M, Paramesh V, Kaviya S, Anuradha E, Paul Solomon F . 3D cell culture systems: advantages and applications. J Cell Physiol. 2014; 230(1):16-26. DOI: 10.1002/jcp.24683. View

13.

Antoni D, Burckel H, Josset E, Noel G . Three-dimensional cell culture: a breakthrough in vivo. Int J Mol Sci. 2015; 16(3):5517-27. PMC: 4394490. DOI: 10.3390/ijms16035517. View

14.

Pickl M, Ries C . Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. Oncogene. 2008; 28(3):461-8. DOI: 10.1038/onc.2008.394. View

15.

Fennema E, Rivron N, Rouwkema J, van Blitterswijk C, de Boer J . Spheroid culture as a tool for creating 3D complex tissues. Trends Biotechnol. 2013; 31(2):108-15. DOI: 10.1016/j.tibtech.2012.12.003. View

16.

Li W, Lee S, Ma M, Kim S, Guye P, Pancoast J . Microbead-based biomimetic synthetic neighbors enhance survival and function of rat pancreatic β-cells. Sci Rep. 2013; 3:2863. PMC: 3790197. DOI: 10.1038/srep02863. View

17.

Wheeler A, Throndset W, Whelan R, Leach A, Zare R, Liao Y . Microfluidic device for single-cell analysis. Anal Chem. 2003; 75(14):3581-6. DOI: 10.1021/ac0340758. View

18.

Andersson H, van den Berg A . Microfabrication and microfluidics for tissue engineering: state of the art and future opportunities. Lab Chip. 2004; 4(2):98-103. DOI: 10.1039/b314469k. View

19.

Choi J, Yang H, Kim B, Kim J, Kim J, Yoo B . Human extracellular matrix (ECM) powders for injectable cell delivery and adipose tissue engineering. J Control Release. 2009; 139(1):2-7. DOI: 10.1016/j.jconrel.2009.05.034. View

20.

Flynn L . The use of decellularized adipose tissue to provide an inductive microenvironment for the adipogenic differentiation of human adipose-derived stem cells. Biomaterials. 2010; 31(17):4715-24. DOI: 10.1016/j.biomaterials.2010.02.046. View